Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Human Microbiotas Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance
  • 2.1.1 Product Type Market Performance (Volume)
  • 2.1.2 Product Type Market Performance (Value)
• 2.2 China Human Microbiotas Market Performance
• 2.3 USA Human Microbiotas Market Performance
• 2.4 Europe Human Microbiotas Market Performance
• 2.5 Japan Human Microbiotas Market Performance
• 2.6 Korea Human Microbiotas Market Performance
• 2.7 India Human Microbiotas Market Performance
• 2.8 Southeast Asia Human Microbiotas Market Performance
• 2.9 South America Human Microbiotas Market Performance

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
• 3.2 China Human Microbiotas Market Performance (Volume)
• 3.3 USA Human Microbiotas Market Performance (Volume)
• 3.4 Europe Human Microbiotas Market Performance (Volume)
• 3.5 Japan Human Microbiotas Market Performance (Volume)
• 3.6 Korea Human Microbiotas Market Performance (Volume)
• 3.7 India Human Microbiotas Market Performance (Volume)
• 3.8 Southeast Asia Human Microbiotas Market Performance (Volume)
• 3.9 South America Human Microbiotas Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Enterome Bioscience
  • 4.1.1 Enterome Bioscience Profiles
  • 4.1.2 Enterome Bioscience Product Information
  • 4.1.3 Enterome Bioscience Human Microbiotas Business Performance
  • 4.1.4 Enterome Bioscience Human Microbiotas Business Development and Market Status
• 4.2 Yakult
  • 4.2.1 Yakult Profiles
  • 4.2.2 Yakult Product Information
  • 4.2.3 Yakult Human Microbiotas Business Performance
  • 4.2.4 Yakult Human Microbiotas Business Development and Market Status
• 4.3 Metabiomics Corporation
  • 4.3.1 Metabiomics Corporation Profiles
  • 4.3.2 Metabiomics Corporation Product Information
  • 4.3.3 Metabiomics Corporation Human Microbiotas Business Performance
  • 4.3.4 Metabiomics Corporation Human Microbiotas Business Development and Market Status
• 4.4 ViThera Pharmaceuticals
  • 4.4.1 ViThera Pharmaceuticals Profiles
  • 4.4.2 ViThera Pharmaceuticals Product Information
  • 4.4.3 ViThera Pharmaceuticals Human Microbiotas Business Performance
  • 4.4.4 ViThera Pharmaceuticals Human Microbiotas Business Development and Market Status
• 4.5 EI Du Pont De Nemours and Company
  • 4.5.1 EI Du Pont De Nemours and Company Profiles
  • 4.5.2 EI Du Pont De Nemours and Company Product Information
  • 4.5.3 EI Du Pont De Nemours and Company Human Microbiotas Business Performance
  • 4.5.4 EI Du Pont De Nemours and Company Human Microbiotas Business Development and Market Status
• 4.6 Merck & Co
  • 4.6.1 Merck & Co Profiles
  • 4.6.2 Merck & Co Product Information
  • 4.6.3 Merck & Co Human Microbiotas Business Performance
  • 4.6.4 Merck & Co Human Microbiotas Business Development and Market Status
• 4.7 Yakult Honsha
  • 4.7.1 Yakult Honsha Profiles
  • 4.7.2 Yakult Honsha Product Information
  • 4.7.3 Yakult Honsha Human Microbiotas Business Performance
  • 4.7.4 Yakult Honsha Human Microbiotas Business Development and Market Status
• 4.8 Microbiome Therapeutics
  • 4.8.1 Microbiome Therapeutics Profiles
  • 4.8.2 Microbiome Therapeutics Product Information
  • 4.8.3 Microbiome Therapeutics Human Microbiotas Business Performance
  • 4.8.4 Microbiome Therapeutics Human Microbiotas Business Development and Market Status
• 4.9 Osel
  • 4.9.1 Osel Profiles
  • 4.9.2 Osel Product Information
  • 4.9.3 Osel Human Microbiotas Business Performance
  • 4.9.4 Osel Human Microbiotas Business Development and Market Status
• 4.10 Second Genome
  • 4.10.1 Second Genome Profiles
  • 4.10.2 Second Genome Product Information
  • 4.10.3 Second Genome Human Microbiotas Business Performance
  • 4.10.4 Second Genome Human Microbiotas Business Development and Market Status
• 4.11 Vedanta Bioscience
• 4.20 Second Genome

5 Market Performance for Manufacturers

• 5.1 Global Human Microbiotas Production (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 Global Human Microbiotas Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 Global Human Microbiotas Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 Global Human Microbiotas Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Global Human Microbiotas Market Performance (Production Point)

• 6.1 Global Human Microbiotas Production (K Units) and Market Share by Regions 2013-2018
• 6.2 Global Human Microbiotas Revenue (M USD) and Market Share by Regions 2013-2018
• 6.3 Global Human Microbiotas Price (USD/Unit) by Regions 2013-2018
• 6.4 Global Human Microbiotas Gross Margin by Regions 2013-2018

7 Development Trend for Regions (Production Point)

• 7.1 Global Human Microbiotas Production (K Units), Revenue (&$B$8&) and Growth Rate 2013-2018
• 7.2 China Human Microbiotas Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.3 USA Human Microbiotas Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.4 Europe Human Microbiotas Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.5 Japan Human Microbiotas Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.6 Korea Human Microbiotas Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.7 India Human Microbiotas Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.8 Southeast Asia Human Microbiotas Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.9 South America Human Microbiotas Production (K Units), Revenue (M USD) and Growth Rate 2013-2018

8 Global Human Microbiotas Market Performance (Consumption Point)

• 8.1 Global Human Microbiotas Consumption and Market Share by Regions 2013-2018
• 8.2 Global Human Microbiotas Consumption Value and Market Share by Regions 2013-2018
• 8.3 Global Human Microbiotas Price (USD/Unit) by Regions 2013-2018

9 Development Trend for Regions (Sales Point)

• 9.1 Global Human Microbiotas Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.2 China Human Microbiotas Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.3 USA Human Microbiotas Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.4 Europe Human Microbiotas Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.5 Japan Human Microbiotas Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.6 Korea Human Microbiotas Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.7 India Human Microbiotas Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.8 Southeast Asia Human Microbiotas Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.9 South America Human Microbiotas Sales and Growth, Sales Value and Growth Rate2013-2018

10 Upstream Source, Technology and Cost

• 10.1 Upstream Source
• 10.2 Technology
• 10.3 Cost

11 Channel Analysis

• 11.1 Market Channel
• 11.2 Distributors

12 Consumer Analysis

• 12.1 Food & Beverage Industry
• 12.2 Medical Industry Industry
• 12.3 Other Industry

13 Market Forecast 2019-2024

• 13.1 Production (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 13.1.1 Global Human Microbiotas Production (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 13.1.2 Global Human Microbiotas Production (K Units) and Growth Rate 2019-2024
  • 13.1.3 China Human Microbiotas Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.4 USA Human Microbiotas Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.5 Europe Human Microbiotas Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.6 Japan Human Microbiotas Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.7 Korea Human Microbiotas Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.8 India Human Microbiotas Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.9 Southeast Asia Human Microbiotas Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.10 South America Human Microbiotas Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 13.2 Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.1 Global Human Microbiotas Consumption and Market Share by Regions 2019-2024
  • 13.2.2 Global Human Microbiotas Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.3 China Human Microbiotas Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.4 USA Human Microbiotas Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.5 Europe Human Microbiotas Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.6 Japan Human Microbiotas Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.7 Korea Human Microbiotas Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.8 India Human Microbiotas Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.9 Southeast Asia Human Microbiotas Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.10 South America Human Microbiotas Sales, Sales Value and Growth Rate 2019-2024
• 13.3 Production (K Units), Revenue (M USD) by Types 2019-2024
  • 13.3.1 Overall Market Performance
  • 13.3.2 Bacteria Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.3.3 Archaea Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.3.4 Protozoa Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.3.5 Algae Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 13.4 Sales by Application 2019-2024
  • 13.4.1 Overall Market Performance
  • 13.4.2 Food & Beverage Sales and and Growth Rate 2019-2024
  • 13.4.3 Medical Industry Sales and and Growth Rate 2019-2024
  • 13.4.4 Other Sales and and Growth Rate 2019-2024
• 13.5 Price (USD/Unit) and Gross Profit
  • 13.5.1 Global Human Microbiotas Price (USD/Unit) Trend 2019-2024
  • 13.5.2 Global Human Microbiotas Gross Profit Trend 2019-2024

14 Conclusion

Geographically, global Human Microbiotas market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Enterome Bioscience
Yakult
Metabiomics Corporation
ViThera Pharmaceuticals
EI Du Pont De Nemours and Company
Merck & Co
Yakult Honsha
Microbiome Therapeutics
Osel
Second Genome
Vedanta Bioscience

On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into
Bacteria
Archaea
Protozoa
Algae
Fungi
Viruses
? ? Animal Parasites
For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Human Microbiotas for each application, including
Food & Beverage
Medical Industry
Other
Fungi
Viruses
? ? Animal Parasites
Production, consumption, revenue, market share and growth rate are the key targets for Human Microbiotas from 2013 to 2024 (forecast) in these regions
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America

If you have any special requirements, please let us know and we will offer you the report as you want.